Global Self-Injection Market Forecast Report to 2027: $86 Billion Market by 2027 at a CAGR of 12.79% – ResearchAndMarkets.com | Nation/World

DUBLIN–(BUSINESS WIRE)–July 14, 2022–

The “Self-Injection Market Intelligence Report – Global Forecast to 2027” report has been added to ResearchAndMarkets.comoffer.

The global Self-Injection Market is expected to reach USD 86,009.00 Million by 2027, from USD 41,757.64 Million in 2021, at a CAGR of 12.79% during the forecast period.

Main conclusions:

  • The Americas Self-Injection Market size was estimated at USD 14,480.50 Million in 2021 and is projected to reach USD 15,973.70 Million in 2022, at a CAGR of 12.26% to reach USD 28,987.16 Million 2027.
  • Asia-Pacific Self-Injection Market Size was estimated at USD 11,116.51 Million in 2021 and is projected to reach USD 12,557.66 Million in 2022, at a CAGR of 13.14% to reach USD 23,321.48 Million USD by 2027.
  • The Europe, Middle East and Africa Self-Injection market size was estimated at USD 16,160.62 million in 2021 and is projected to reach USD 18,199.61 million in 2022, at a CAGR of 13.03% for reach USD 33,700.35 million by 2027.

Segmentation and market coverage:

The years 2019 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and the years from 2023 to 2027 are considered as the forecast period.

The report categorizes self-injections to forecast revenue and analyze trends in each of the following submarkets:

Type:

  • Auto-injectors
  • Needle-free injectors
  • Pen Injectors
  • Portable injectors

Use:

Distribution channel:

  • Hospital pharmacies
  • Online pharmacies
  • Private clinics

Application to therapeutic areas:

  • Autoimmune diseases
    • AIDS
    • allergies
    • Cancer
    • Irritable bowel disorders
    • Multiple sclerosis
    • Psoriasis
  • Emergency drugs
    • Anaphylactic socks
    • Migraine
  • Hormone replacement therapies
    • beta-interferon
    • Erythropoietin
    • follicle stimulating hormone
    • Heparin
    • Insulin
    • parathyroid hormone
    • Parkinson’s

Company Profiles:

  • AbbVie Inc.
  • Antares Pharma, Inc.
  • Baxter International, Inc.
  • Becton, Dickinson and company
  • Credence MedSystems, Inc.
  • DALI medical devices
  • Eli Lilly and company
  • Activate Injections, Inc.
  • Gerresheimer S.A.
  • Island Corporation
  • Owen Mumford Limited
  • PenJet Corporation
  • Pfizer Inc.
  • PharmaJet, Inc.
  • Recipharm AB
  • SCHOTT S.A.
  • SHL Group
  • Terumo Company
  • West Pharmaceutical Services, Inc.
  • Wilhelm Haselmeier GmbH & Co. KG
  • Ypsomed Group

Main topics covered:

1. Preface

1.1. Study objectives

1.2. Market segmentation and coverage

1.3. Years Considered for Study

1.4. Currency and price

1.5. Language

1.6. Limits

1.7. Hypotheses

1.8. Stakeholders

2. Research methodology

3. Market Overview

4. Americas Self-Injection Market

4.1. Introduction

4.2. Argentina

4.3. Brazil

4.4. Canada

4.5. Mexico

4.6. United States

5. Asia-Pacific self-injection market

5.1. Introduction

5.2. Australia

5.3. China

5.4. India

5.5. Indonesia

5.6. Japan

5.7. Malaysia

5.8. Philippines

5.9. Singapore

5.10. South Korea

5.11. Taiwan

5.12. Thailand

6. Europe, Middle East and Africa Self-Injection Market

6.1. Introduction

6.2. France

6.3. Germany

6.4. Italy

6.5. Netherlands

6.6. Qatar

6.7. Russia

6.8. Saudi Arabia

6.9. South Africa

6.10. Spain

6.11. United Arab Emirates

6.12. UK

7. Enterprise Usability Profiles

  • AbbVie Inc.
  • Antares Pharma, Inc.
  • Baxter International, Inc.
  • Becton, Dickinson and company
  • Credence MedSystems, Inc.
  • DALI medical devices
  • Eli Lilly and company
  • Activate Injections, Inc.
  • Gerresheimer S.A.
  • Island Corporation
  • Owen Mumford Limited
  • PenJet Corporation
  • Pfizer Inc.
  • PharmaJet, Inc.
  • Recipharm AB
  • SCHOTT S.A.
  • SHL Group
  • Terumo Company
  • West Pharmaceutical Services, Inc.
  • Wilhelm Haselmeier GmbH & Co. KG
  • Ypsomed Group

For more information on this report, visit https://www.researchandmarkets.com/r/g9af8y

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world’s leading source of international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, top companies, new products and the latest trends.

Show source version on businesswire.com:https://www.businesswire.com/news/home/20220714005727/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Officer

[email protected] EST business hours, call 1-917-300-0470

For US/CAN call toll free 1-800-526-8630

For GMT office hours call +353-1-416-8900

KEYWORD: UNITED STATES MIDDLE EAST AFRICA LATIN AMERICA SOUTH AMERICA CENTRAL AMERICA NORTH AMERICA ASIA PACIFIC EUROPE

INDUSTRY KEYWORD: MEDICAL DEVICES MEDICAL SUPPLIES HOSPITALS OTHER HEALTH BIOTECHNOLOGY MANAGED CARE AIDS PHARMACEUTICAL HEALTH ONCOLOGY

SOURCE: Research and Markets

Copyright BusinessWire 2022.

PUBLISHED: 07/14/2022 12:10 PM / DISK: 07/14/2022 12:12 PM

http://www.businesswire.com/news/home/20220714005727/en

Copyright BusinessWire 2022.